The Clinical Utility of Genetic Markers in NSCLC



About this Webinar

Date: Wednesday, November 28, 2012

Author: Anguiano, Arturo, MD
Vice Chairman, Genetics and Chief Director, Cytogenetics
Quest Diagnostics Nichols Institute
San Juan Capistrano, CA  
Also by this Author 

Category: Webinar

Description: Arturo Anguiano, MD discusses the epidemiology of non-small cell lung cancer (NSCLC) and established as well as emerging biomarkers that can guide clinical decision-making related to the use of approved and investigational targeted therapies for these patients.

Learning objectives — at the conclusion of this program participants will be able to:

• Discuss NSCLC in a medical context and communicate current disease epidemiology and key statistics
• Describe the use of established genetic markers for selecting targeted NSCLC therapies
• Identify emerging genetic markers relevant to the treatment of NSCLC